What is the price target for BZ stock?
28 analysts have analysed BZ and the average price target is 26.7 USD. This implies a price increase of 97.59% is expected in the next year compared to the current price of 13.515.
KANZHUN LTD - ADR (BZ) Forecast, Price Target & Analyst Ratings
NASDAQ:BZ • US48553T1060
Current stock price
13.515 USD
+0.16 (+1.16%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KANZHUN LTD - ADR (BZ).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 20, 2026
- Period
- Q4 / 2025
- EPS Estimate
- CN¥1.99
- Revenue Estimate
- 2.125B
Price Target Details & History
Consensus Price Target and Range
Mean target
$26.70
Upside
+ 97.59%
From current price of $13.52 to mean target of $26.70, Based on 28 analyst forecasts
Low
$23.23
Median
$26.52
High
$29.40
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
28 Wall Street analysts provided a forecast for the next 12 months for BZ. The average price target is 26.7 USD. This implies a price increase of 97.59% is expected in the next year compared to the current price of 13.515.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.29%
BZ was analyzed by 28 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BZ.
In the previous month the buy percentage consensus was at a similar level.
BZ was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-19 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-21 | UBS | Upgrade | Neutral -> Buy |
| 2025-08-20 | Jefferies | Maintains | Buy -> Buy |
| 2025-03-13 | Barclays | Maintains | Overweight -> Overweight |
| 2024-12-09 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2024-12-09 | Barclays | Maintains | Overweight -> Overweight |
| 2024-12-09 | Baird | Downgrade | Outperform -> Market Perform |
| 2024-11-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-30 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-22 | UBS | Maintains | Neutral -> Neutral |
| 2024-05-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-13 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-13 | New Street Research | Upgrade | Neutral -> Buy |
| 2024-03-12 | Macquarie | Upgrade | Neutral -> Outperform |
| 2023-12-20 | New Street Research | Initiate | Neutral |
| 2023-12-13 | JP Morgan | Initiate | Overweight |
| 2023-09-01 | UBS | Downgrade | Buy -> Neutral |
| 2023-08-31 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-30 | Bernstein | Maintains | Outperform -> Outperform |
| 2023-08-22 | Macquarie | Downgrade | Outperform -> Neutral |
| 2023-08-21 | Macquarie | Downgrade | Outperform -> Neutral |
| 2023-07-20 | Citigroup | Initiate | Buy |
| 2023-05-03 | Macquarie | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 20, 2026
- Period
- Q4 / 2025
- EPS Estimate
- CN¥1.99
- Revenue Estimate
- 2.125B
- Revenue Q2Q
- 16.53%
- EPS Q2Q
- 25.95%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.47%
EPS (1 Month)
0.63%
EPS (3 Months)
0.63%
Next Earnings Summary
BZ is expected to report earnings on 5/20/2026. The consensus EPS estimate for the next earnings is 1.99 USD and the consensus revenue estimate is 2.13B USD.
The next earnings revenue estimate has been revised downward by 0.47% in the past 3 months.
Full Analyst Estimates 2025 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.511B 5.92% | 5.952B 31.94% | 7.356B 23.58% | 8.503B 15.60% | 9.624B 13.18% | 10.894B 13.20% | 12.229B 12.25% | 12.921B 5.66% | 14.16B 9.59% | 15.537B 9.72% | 16.902B 8.79% | 18.406B 8.90% | |
| EBITDA YoY % growth | 10.6M 101.09% | 839.723M 7,821.92% | 1.675B 99.45% | 3.948B 135.73% | 4.527B 14.67% | 5.169B 14.18% | 5.345B 3.40% | 5.718B 6.98% | 6.258B 9.44% | 6.852B 9.49% | 7.413B 8.19% | 8.042B 8.49% | |
| EBIT YoY % growth | -129.5M 87.65% | 580.971M 548.63% | 1.173B 101.89% | 3.253B 177.34% | 3.946B 21.30% | 4.857B 23.09% | 3.777B -22.24% | 4.035B 6.83% | 4.46B 10.53% | 4.877B 9.35% | N/A | N/A | |
| Operating Margin | -2.87% | 9.76% | 15.95% | 38.26% | 41.00% | 44.58% | 30.89% | 31.23% | 31.50% | 31.39% | N/A | N/A | |
| EPS YoY % growth | 1.77 3.52% | 4.78 170.06% | 5.97 24.90% | 8.01 34.25% | 9.02 12.57% | 10.58 17.29% | 11.62 9.79% | 5.26 -54.76% | 4.59 -12.69% | 5.06 10.24% | 5.57 10.08% | 6.12 9.87% |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.99 25.95% | 1.77 2.81% | 2.30 10.07% | 2.46 14.11% | 2.33 17.21% | 2.37 33.80% | 2.76 19.95% | 3.04 23.28% | 2.68 14.82% |
| Revenue Q2Q % growth | 2.125B 16.53% | 2.259B 17.46% | 2.466B 17.29% | 2.549B 17.83% | 2.492B 17.27% | 2.78B 23.06% | 3.093B 25.43% | 2.897B 13.65% | 2.931B 17.62% |
| EBITDA Q2Q % growth | 727.64M -9.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 877.24M 130.51% | 867.93M 97.35% | 1.001B 53.72% | 1.052B 53.10% | N/A | N/A | N/A | N/A | N/A |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.03%
EPS Next 5 Year
-2.51%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
12.99%
Revenue Next 5 Year
11.34%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
33.45%
EBIT Next 5 Year
21.33%
KANZHUN LTD - ADR / BZ Forecast FAQ
Can you provide the upcoming earnings date for KANZHUN LTD - ADR?
KANZHUN LTD - ADR (BZ) will report earnings on 2026-05-20, before the market open.
What are the consensus estimates for BZ stock next earnings?
The consensus EPS estimate for the next earnings of KANZHUN LTD - ADR (BZ) is 1.99 USD and the consensus revenue estimate is 2.13B USD.
What is the expected long term growth rate for KANZHUN LTD - ADR (BZ)?
The expected long term growth rate for KANZHUN LTD - ADR (BZ) is 12.99%.